Literature DB >> 1931932

Fluvoxamine: clinical trials and clinical use.

C P Freeman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1931932      PMCID： PMC1188308     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  9 in total

Review 1.  Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.

Authors:  P Benfield; A Ward
Journal:  Drugs       Date:  1986-10       Impact factor: 9.546

2.  The psychopharmacological effects of repeated doses of fluvoxamine, mianserin and placebo in healthy human subjects.

Authors:  H V Curran; M Lader
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

3.  A double-blind comparison of fluvoxamine, imipramine and placebo in depressed patients.

Authors:  K R Norton; L I Sireling; A V Bhat; B Rao; E S Paykel
Journal:  J Affect Disord       Date:  1984-12       Impact factor: 4.839

4.  Fluvoxamine and clomipramine in depressed patients. A double-blind clinical study.

Authors:  C J Klok; G J Brouwer; H M van Praag; D Doogan
Journal:  Acta Psychiatr Scand       Date:  1981-07       Impact factor: 6.392

5.  Fluvoxamine maleate, a serotonergic antidepressant; a comparison with chlorimipramine.

Authors:  B S Coleman; B A Block
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1982       Impact factor: 5.067

6.  Pharmaco-EEG profiles of antidepressants. Pharmacodynamic studies with fluvoxamine.

Authors:  B Saletu; J Grünberger; P Rajna
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

7.  A double-blind placebo-controlled study of fluvoxamine and imipramine in out-patients with primary depression.

Authors:  T M Itil; R K Shrivastava; S Mukherjee; B S Coleman; S T Michael
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

8.  A double-blind comparative study of the clinical efficacy of fluvoxamine and chlorimipramine.

Authors:  P Dick; E Ferrero
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

9.  A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.

Authors:  R A Dominguez; B J Goldstein; A F Jacobson; R M Steinbook
Journal:  J Clin Psychiatry       Date:  1985-03       Impact factor: 4.384
  9 in total
  2 in total

1.  The use of antidepressant drugs in general practice. A questionnaire survey.

Authors:  K Matthews; J M Eagles; C A Matthews
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

2.  Fluvoxamine for the Early Treatment of COVID-19: A Meta-analysis of Randomized Clinical Trials.

Authors:  Christina M Guo; Ofir Harari; Cameron Chernecki; Kristian Thorlund; Jamie I Forrest
Journal:  Am J Trop Med Hyg       Date:  2022-03-09       Impact factor: 3.707
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.